The serotonin system in autism

Current Opinion in Pediatrics

Volumn 8, Issue 4, 1996, Pages 348-354

  Cook Jr , Edwin H ^a   Leventhal, Bennett L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; RISPERIDONE; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN;

AGGRESSION; AUTISM; CLINICAL TRIAL; HUMAN; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; STEREOTYPY; THROMBOCYTE;

EID: 10544234621     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199608000-00008     Document Type: Review

References (81)

1. Schain RJ, Freedman DX: Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961, 58:315-320.
2. Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, Minderaa RB, Hansen CR, Young JG: Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987, 28:885-900.
3. Cook EH: Autism: review of neurochemical investigation. Synapse 1990, 6:292-308.
4. Anderson GM, Feibel FC, Cohen DJ: Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Lite Sci 1987, 40:1063-1070.
5. Cook EH, Leventhal BL, Freedman DX: Free serotonin in plasma: autistic children and their first-degree relatives. Biol Psychiatry 1988, 24:488-491.
6. Kuperman S, Beeghly JH, Burns TL, Tsai LY: Serotonin relationships of autistic probands and their first-degree relatives. J Am Acad Child Psychiatry 1985, 24:186-190.
7. Abramson RK, Wright HH, Carpenter R, Brennan W, Lumpuy O, Cole E, Young SR: Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 1989, 19:397-407.
8. Leventhal BL, Cook EH, Morford M, Ravitz A, Freedman DX: Relationships of whole blood serotonin and plasma norepinephrine within families of autistic children. J Autism Dev Disorder 1990, 20:499-511.
9. Cook EH, Leventhal BL, Heller W, Metz J, Wainwright M, Freedman DX: Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci 1990, 2:268-274.
10. Cuccaro ML, Wright HH, Abramson RK, Marsteller FA, Valentine J: Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. J Neuropsychiatry Clin Neurosci 1993, 5:94-101.
11. Piven J, Tsai G, Nehme E, Coyle JT, Folstein SE: Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 1991, 21:51-59.
12. Ritvo E, Yuwiler A, Geller E, Plotkin S, Mason A, Saeger K: Maturational changes in blood serotonin levels and platelet counts. Biochem Med 1971, 5:90-96.
13. Lesch KP, Wolozin BL, Murphy DL, Reiderer P: Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993, 60:2319-2322.
14. 2A receptor. J Neurochem 1994, 63:465-469.
15. McBride PA, Anderson GM, Hertzig ME, Sweeney JA, Kream J, Cohen DJ, Mann JJ: Serotonergic responsivity in male young adults with autistic disorder. Arch Gen Psychiatry 1989, 46:205-212.
16. 2-serotonin receptor binding sites in autistic children and their first-degree relatives. Biol Psychiatry 1991, 30:1-10.
17. Cook E, Arora R, Anderson G, Berry-Kravis E, Yan S-Y, Yeoh H, Sklena P, Charak D, Leventhal B: Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 1993, 52:2005-2015.
18. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 1992, 257:977-980.
19. 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. Mol Pharmacol 1993, 43:313-319.
20. Monsma F JR, Shen Y, Ward R, Hamblin M, Sibley D: Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993, 43:320-327.
21. 7) positively coupled to adenylate cyclase. J Biol Chem 1993, 268:23422-23426.
22. Kuperman S, Beeghly JHL, Burns TL, Tsai LY: Association of serotonin concentration to behavior and IQ in autistic children. J Aut Dev Disord 1987, 17:133-140.
23. Lord C, Rutter M, Le Couteur A: Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994, 24:659-685.
24. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Schopler E: Autism Diagnostic Observation Schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 1989, 19:185-212.
25. Cook EH, Terry EJ, Heller W, Leventhal BL: Fluoxetine treatment of borderline mentally retarded adults with obsessive-compulsive disorder. J Clin Psychopharmacol 1990, 10:228-229.
26. Mehlinger R, Scheftner WA, Poznanski E: Fluoxetine and autism. J Am Acad Child Adolesc Psychiatry 1990, 29:985.
27. McDougle CJ, Price LH, Goodman WK: Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report. J Autism Dev Disord 1990, 20:537-543.
28. Todd RD: Fluoxetine in autism. Am J Psychiatry 1991, 148:1089.
29. Cook E, Rowlett R, Jaselskis C, Leventhal B: Fluoxetine treatment of patients with autism and mental retardation. J Am Acad Child Adolesc Psychiatry 1992, 31:739-745.
30. Gordon C, State R, Nelson J, Hamburger S, Rapoport J: A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 1993, 50:441-447.
31. McDougle C, Naylor S, Cohen D, Volkmar F, Heninger G, Price L: A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996, 53:in press. This paper represents the first double-blind study in which both efficacy and the absence of long-term irreversible side effects (ie, neuroleptics) have been replicated for a class of medications-potent serotonin transporter inhibitors-in the treatment of core symptoms of autistic disorder. This paper is also significant because it is the first double-blind study showing efficacy for a selective serotonin reuptake inhibitor in autistic disorder, confirming an earlier systematic open trial with fluoxetine. Although the core social and communicative impairments are not addressed by this class of medications, symptoms such as the performance of rituals, preoccupations, and routines associated with anxiety and aggression often respond.
32. Lewis M, Bodfish J, Powell S, Golden R: Clomipramine treatment for stereotypy and related repetitive movement disorders associated with mental retardation. Am J Ment Retard 1995, 100:299-312.
33. Cook E, Metz J, Leventhal B, Lebovitz M, Nathan M, Semerdjian S, Brown T, Cooper M: Fluoxetine effects on cerebral glucose metabolism. Neuroreport 1994, 5:1745-1748.
34. Chaput Y, de Montigny C, Blier P: Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments: an in vivo electrophysiologic study in the rat. Neuropsychopharmacology 1991, 5:219-229.
35. Purdon SE, Lit W, Labelle A, Jones BD: Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry 1994, 39:400-405.
36. Casaer P, Walleghem D, Vandenbussche I, Huang M-L, De Smedt G: Pharmacokinetics and safety of risperidone in autistic children. Pediatr Neurol 1994, 11:89.
37. Seeman P, Van Tol H: Dopamine receptor pharmacology. Trends Pharmacol Sci 1994, 15:264-270.
38. Roth B, Craigo S, Choudhary S, Uluer A, Monsma Jr F, Hen Y, Meltzer H, Sibley D: Binding of typical and atypical antipsychotic drugs to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 1994, 268:1403-1410.
39. McDougle C, Naylor S, Cohen D, Aghajanian G, Heninger G, Price L: Effects of tryptophan depletion in drug-free adults with autism. Arch Gen Psychiatry 1996, 53: in press. This study shows worsened stereotypic behavior in subjects with autism who had undergone acute dietary depletion of tryptophan (which acutely reduces serotonin synthesis).
40. D' Eufemia P, Finocchiaro R, Celli M, Viozzi L, Monteleone D, Giardini O: Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. Biomed Pharmacother 1995, 49:288-292. Reduction in the ratio of tryptophan levels to large neutral amino acid levels has been shown in other studies to lead to decreased tryptophan transport across the blood-brain barrier and subsequently to decreased serotonin synthesis. This is an interesting study in relationship to the finding of worsening of stereotypic symptoms after tryptophan depletion.
41. Bauman M, Kemper T: Neuroanatomic observations of the brain in autism. In The Neurobiology of Autism. Edited by Bauman M, Kemper T. Baltimore: Johns Hopkins University Press; 1994:119-145.
42. Raymond GV, Bauman ML, Kemper TL: Hippocampus in autism: a Golgi analysis. Acta Neuropathol 1996, 91:117-119.
43. 7) implicated in the regulation of mammalian circadian rhythms. Neuron 1993, 11:449-458.
44. Sikich L, Hickok JM, Todd RD: 5-HT1A receptors control neurite branching during development. Brain Res Dev Brain Res 1990, 56:269-274.
45. Whitaker-Azmitia PM, Murphy R, Azmitia EC: Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res 1990, 528:155-158.
46. del Olmo E, Diaz A, Guirao-Pineyro M, del Arco C, Pascual J, Pazos A: Transient localization of 5-HT1A receptors in human cerebellum during development. Neurosci Lett 1994, 166:149-152.
47. 2 receptors in the bat brain: neurochemical identification of cell types by immunocytochemistry. Neuropsychopharmacology 1994, 11:157-166.
48. Ward RP, Hamblin MW, Lachowicz JE, Hoffman BJ, Sibley DR, Dorsa DM: Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience 1995, 64:1105-1111.
49. 1A receptor. Nature 1988, 335:358-360.
50. Goldman D, Lappalainen J, Ozaki N, Nakhai B, Pesonen U, Koulu M, Giblin B, Nielsen D, Linnoila M, Dean M: Polymorphism and genetic mapping of six human serotonin receptor genes. Soc Neurosci Abstr 1994, 20:1266.
51. Nakhai B, Nielsen D, Linnoila M, Goldman D: Two naturally occurring amino acid substitutions in the human 5HT1A receptor: 5HT1A-22 Gly-Ser and 5HT1a-28 IIe-Val. Biochem Biophys Res Commun 1995, 210:530-536.
52. Erdmann J, Shimron-Abarbanell D, Cichon S, Albus M, Maier W, Lichtermann D, Minges J, Reuner U, Franzek E, Ertl MA, et al.: Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene. Am J Med Genet 1995, 60:393-399.
53. Ramboz S, Saudou F, Amara DA, Belzung C, Segu L, Misslin R, Buhot MC, Hen R: 5-HT1B receptor knock out: behavioral consequences. Behav Brain Res 1995, 73:305-312.
54. 1D receptor genes. Trends Pharmacol Sci 1992, 13:152-159.
55. Lappalainen J, Dean M, Charbonneau L, Virkkunen M, Linnoila M, Goldman D: Mapping of the serotonin 5-HT1DBeta autoreceptor gene on chromosome 6 and direct analysis for sequence variants. Am J Med Genet 1995, 60:157-161.
56. 1B receptor. Science 1994, 265:1875-1878.
57. Nöthen M, Erdmann J, Shimron-Abarbanell D, Propping P: Identification of genetic variation in the human serotonin 1Dβ receptor gene. Biochem Biophys Res Comm 1994, 205:1194-1200.
58. Ozaki N, Lappalainen J, Dean M, Virkkunen M, Linnoila M, Goldman D: Mapping of the serotonin 5-HT1DAlpha autoreceptor gene (HTR1D) on chromosome 1 using a silent polymorphism in the coding region. Am J Med Genet 1995, 60:162-164.
59. 1-like subtype. Proc Natl Acad Sci U S A 1992, 89:5517-5521.
60. Levy F, Gudermann T, Birnbaumer M, Kaumann A, Birnbaumer L: Assignment of the gene encoding the 5-HT1E serotonin receptor (S31) (locus HTR1E) to human chromosome 6q14-q15. Genomics 1994, 22:637-640.
61. 1E-like-5-hydroxytryptamine receptor genes. Proc Natl Acad Sci U S A 1993, 90:2184-2188.
62. Julius D, Huang KN, Livelli TJ, Axel R, Jessell TM: The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Prac Natl Acad Sci U S A 1990, 87:928-932.
63. 2A receptor in patients with seasonal affective disorder and in contols. Biol Psychiatry 1996, in press.
64. Erdmann J, Shimron-Abarbanell D, Rietschel M, Albus M, Maier W, Koerner J, Bondy B, Chen K, Shih JC, Knapp M, Propping P, Noethen MM: Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association anaylysis in schizophrenia. Hum Genet 1996, 97:614-619.
65. 2B serotonin receptor. FEBS Lett 1994, 342:85-90.
66. Le Coniat M, Choi DS, Maroteaux L, Launay JM, Berger R: The 5-HT2B receptor gene maps to 2q36.3-2q37.1. Genomics 1996, 32:172-173.
67. Julius D, MacDermott A, Axel R, Jessel T: Molecular characterization of a functional cDNA encoding the serotonin 1C receptor. Science 1988, 241:558-564.
68. 2C receptor gene (HTR2C). Genomics 1995, 27:274-279.
69. 2C serotonin receptors. Nature 1995, 374:542-546.
70. Kaufman MJ, Hartig PR, Hoffman BJ: Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus. J Neurochem 1995, 64:199-205.
71. Uetz P, Adelatty F, Villaroel A, Rappold G, Weiss B, Koenen M: Organization of the murine 5-HT3 receptor gene and assignment to human chromosome 11. FEBS Lett 1994, 339:302-306.
72. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S: Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol 1995, 48:407-416.
73. Weiss B, Mertz A, Schroeck E, Koenen M, Rappold G: Assignment of a human homolog of the mouse HTr3 receptor gene to chromosome 11q23.1-q23.2. Genomics 1995, 29:304-305.
74. 4 receptor coupled to stimulation of adenylate cyclase. Soc Neurosci Abstr 1994, 20:1266.
75. Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, Bard JA, Vaysse PJJ, Hartig PR, Branchek TA, Weinshank RL: The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J 1995, 14:2806-2815.
76. Schanen NC, Scherer SW, Tsui LC, Francke U: Assignment of the 5-hydroxytryptamine (serotonin) receptor 5A gene (HTR5A) to human chromosome band 7q36.1. Cytogenet Cell Genet 1996, 72:187-188.
77. 5B receptors: cloning and functional expression. Soc Neurosci Abstr 1994, 20:1160.
78. Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW: Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 1996, 66:47-56.
79. Gelernter J, Rao P, Pauls D, Hamblin M, Sibley D, Kidd K: Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of linkage with Tourette syndrome. Genomics 1995, 26:207-209.
80. Goldman D, Nielsen D, Okada M, Adamson M, Lappalainen J, Nalhotra N, Pesonen U, Koulu M, Eggert M, Virkkunen M, Ozaki N, Linnoila M: Molecular genetics of impaired impulse control and early onset alcoholism [abstract]. Biol Psychiatry 1996, 39:212.
81. Gelernter J, Freimer M: Pstl RFLP at the SERT locus. Hum Mol Genet 1994, 3:383.